Latest filing published 03 Feb 2022 for Syndax Pharmaceuticals Inc, €11k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Alexander Nolte: trading record in brief
Alexander Nolte, listed as senior executive, appears in our data through filings on Syndax Pharmaceuticals Inc shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 31 January 2022 and the latest from 1 February 2022.
The open-market record consists of 1 sale worth €14k, with no purchase.
The record was last updated on 3 February 2022 with an open-market sale (€14k) in Syndax Pharmaceuticals Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Alexander Nolte
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 968 shares@ US$12.39100.0% of flowCommon StockSEC:0001562180-22-001077:0
1 of 1 declaration
